What is VRTX's current stock price?

As of now, VRTX is trading at $437.01, with a daily change of -1.14%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

VRTX Stock Analysis & IQ Rating | Vertex Pharma

VRTX

Vertex Pharma

$437.01

-$5.03 | -1.14%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$519.68

MKT CAP

$110.88B

52W Low

$362.5

VOL

$709.63K

P/E Ratio

43.58

AVG VOL

$1.45M

RSI

52.63

TREND

Uptrend

VRTX Stock IQ

Login to see Vertex Pharma (VRTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

VRTX Target Price

Login to display

Strengths

VRTX Rewards

Earnings are forecast to grow

VRTX Rewards

Upgraded on attractively valued

VRTX Rewards

Outperform the market

VRTX Rewards

Expands stock buyback program

VRTX Price Performance

$434.19 (+0.65%)

$391.36 (+11.66%)

$458.49 (-4.68%)

$405.27 (+7.83%)

1year

6month

3month

1month

VRTX Risk Level

VRTX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

VRTX Analysts Opinion

VRTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

VRTX Analysts Opinion

VRTX Analysts opinion is positive and also has improved from the past 3 months

VRTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

90%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

100%

VRTX Street Sentiment

VRTX Street Sentiment is extremely bullish and have positive views on the near-term outlook

VRTX Performance Sentiment

Sentiments overview associated with VRTX events and the stock performance.

90%

10%

Positive

Negative

18 out of 20
events present

2 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$442.04

Resistance
Price

$416.16

Current Price Range

$463.13

Show methods +

VRTX Latest Analysis +

Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Mon Dec 8, 2025

$442.04 | -2.95%

Momentum

$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today. Vertex Pharmaceuticals (NASDAQ:) has outperformed the market over the past 15 years by 6.85% on an annualized basis producing an average annual return of 18.9%. Currently Vertex Pharmaceuticals has a market capitalization of $116.23 billion.

Fri Dec 5, 2025

$455.48 | -0.41%

Activity

Vertex and CPA.com Announce AI-Driven Expansion of Tax Compliance Services for Accounting Firms. KING OF PRUSSIA Pa. Dec. 05 2025 (GLOBE NEWSWIRE) -- (NASDAQ:VERX) (Vertex or the Company) a leading global provider of indirect tax solutions and CPA.com the trusted partner in accounting and finance transformation today announced an expansion of their partnership to include an AI-driven solution in collaboration with Kintsugi. The application helps accounting firms of all sizes and tax expertise d

Fri Dec 5, 2025

$455.48 | -0.41%

Activity

1 Reason Ill Never Sell Vertex Pharmaceuticals Stock. Key PointsVertex Pharmaceuticals dominates the cystic fibrosis treatment market and recently has expanded into other therapeutic areas.

Thu Dec 4, 2025

$457.36 | -1.25%

Momentum

Vertex upgraded at Morgan Stanley on kidney pipeline.

Wed Dec 3, 2025

$463.13 | +6.92%

Rating

Check Out What Whales Are Doing With VRTX. Investors with a lot of money to spend have taken a bearish stance on ).And retail traders should know.We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with VRTX it often means somebody knows something is about to happen.Today Benzinga'.s options scanner spotted 27 o

Wed Dec 3, 2025

$463.13 | +6.92%

Activity

ish Two Hundred Day Moving Average Cross - VRTX. In trading on Wednesday shares of Vertex Pharmaceuticals Inc. (Symbol: VRTX) crossed above their 200 day moving average of $443.02 changing hands as high as $457.17 per share. Vertex Pharmaceuticals Inc. shares are currently trading up about 4.9% on the day. The chart belo

Wed Dec 3, 2025

$463.13 | +6.92%

Momentum

Technical

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript.

Wed Dec 3, 2025

$463.13 | +6.92%

Activity

Vertex Innovations Names Grant Cooper Chief Revenue Officer. Vertex Innovations a national provider of telecommunications and data-center infrastructure services has appointed Grant Cooper as Chief Revenue Officer. Cooper brings more than 20 years of experience across telecommunications wireless infrastructure and technology services including leadership roles in sales operations and business development.

Tue Dec 2, 2025

$433.15 | +1.77%

Activity

Kyivstar and Ukrainian Ministry of Digital Transformation Select Google Gemma as the Foundation for Ukraines National LLM. Dubai and Kyiv December 1 2025: VEON Ltd. (Nasdaq: VEON) announces that Kyivstar (Nasdaq: KYIV. KYIVW) together with the WINWIN AI Center of Excellence under Ukraines Ministry of Digital Transformation has selected Google Gemma as the base model for developing Ukrainian LLM Ukraines own national large language model (LLM) leveraging Googles Vertex AI infrastructure for compu

Mon Dec 1, 2025

$425.60 | -1.85%

Activity

FAQ About VRTX Stock Insights

What is VRTX current stock price?

What are VRTX stock strengths?

What is VRTX Risk Level?

What is VRTX market cap and volume?

What is VRTX current Stock IQ?

Should I buy VRTX stock right now?

Is VRTX a Strong Buy right now?

What does a 'Strong Buy' rating mean for VRTX?

What does a 'Strong Sell' rating mean for VRTX?

What factors influence VRTX's Stock IQ?

Explore our VRTX Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored VRTX Stock Strategies
Effective Risk Management

FIND US ON

Receive our VRTX Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

VRTX

Vertex Pharma

Current Price

$437.01

-$5.03 | -1.14%

52W High

$519.68

MKT CAP

$110.88B

52W Low

$362.5

VOL

$709.63K

P/E Ratio

43.58

AVG VOL

$1.45M

RSI

52.63

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

VRTX Rewards

Earnings are forecast to grow

VRTX Rewards

Upgraded on attractively valued

VRTX Rewards

Outperform the market

VRTX Rewards

Expands stock buyback program

VRTX Price Performance

$434.19 (+0.65%)

$391.36 (+11.66%)

$458.49 (-4.68%)

$405.27 (+7.83%)

1year

6month

3month

1month

VRTX Analysts Opinion

VRTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

VRTX Analysts Opinion

VRTX Analysts opinion is positive and also has improved from the past 3 months

VRTX Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

90%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

67%

100%

VRTX Street Sentiment

VRTX Street Sentiment is extremely bullish and have positive views on the near-term outlook

VRTX Risk Level

VRTX has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Investors losing confidence

Low

LOW

HIGH

VRTX Performance Sentiment

Sentiments overview associated with VRTX events and the stock performance.

90%

10%

Positive

Negative

18 out of 20
events present

2 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$442.04

Resistance
Price

$416.16

Current Price Range

$463.13

Show methods +

VRTX Stock IQ

Login to unlock Vertex Pharma (VRTX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

VRTX Latest Analysis

Why Vertex Pharmaceuticals (VRTX) is a Top Momentum Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Mon Dec 8, 2025

$442.04 | -2.95%

Momentum

$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today. Vertex Pharmaceuticals (NASDAQ:) has outperformed the market over the past 15 years by 6.85% on an annualized basis producing an average annual return of 18.9%. Currently Vertex Pharmaceuticals has a market capitalization of $116.23 billion.

Fri Dec 5, 2025

$455.48 | -0.41%

Activity

Vertex and CPA.com Announce AI-Driven Expansion of Tax Compliance Services for Accounting Firms. KING OF PRUSSIA Pa. Dec. 05 2025 (GLOBE NEWSWIRE) -- (NASDAQ:VERX) (Vertex or the Company) a leading global provider of indirect tax solutions and CPA.com the trusted partner in accounting and finance transformation today announced an expansion of their partnership to include an AI-driven solution in collaboration with Kintsugi. The application helps accounting firms of all sizes and tax expertise d

Fri Dec 5, 2025

$455.48 | -0.41%

Activity

1 Reason Ill Never Sell Vertex Pharmaceuticals Stock. Key PointsVertex Pharmaceuticals dominates the cystic fibrosis treatment market and recently has expanded into other therapeutic areas.

Thu Dec 4, 2025

$457.36 | -1.25%

Momentum

Vertex upgraded at Morgan Stanley on kidney pipeline.

Wed Dec 3, 2025

$463.13 | +6.92%

Rating

Check Out What Whales Are Doing With VRTX. Investors with a lot of money to spend have taken a bearish stance on ).And retail traders should know.We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with VRTX it often means somebody knows something is about to happen.Today Benzinga'.s options scanner spotted 27 o

Wed Dec 3, 2025

$463.13 | +6.92%

Activity

ish Two Hundred Day Moving Average Cross - VRTX. In trading on Wednesday shares of Vertex Pharmaceuticals Inc. (Symbol: VRTX) crossed above their 200 day moving average of $443.02 changing hands as high as $457.17 per share. Vertex Pharmaceuticals Inc. shares are currently trading up about 4.9% on the day. The chart belo

Wed Dec 3, 2025

$463.13 | +6.92%

Momentum

Technical

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Citi Annual Global Healthcare Conference 2025 Transcript.

Wed Dec 3, 2025

$463.13 | +6.92%

Activity

Vertex Innovations Names Grant Cooper Chief Revenue Officer. Vertex Innovations a national provider of telecommunications and data-center infrastructure services has appointed Grant Cooper as Chief Revenue Officer. Cooper brings more than 20 years of experience across telecommunications wireless infrastructure and technology services including leadership roles in sales operations and business development.

Tue Dec 2, 2025

$433.15 | +1.77%

Activity

Kyivstar and Ukrainian Ministry of Digital Transformation Select Google Gemma as the Foundation for Ukraines National LLM. Dubai and Kyiv December 1 2025: VEON Ltd. (Nasdaq: VEON) announces that Kyivstar (Nasdaq: KYIV. KYIVW) together with the WINWIN AI Center of Excellence under Ukraines Ministry of Digital Transformation has selected Google Gemma as the base model for developing Ukrainian LLM Ukraines own national large language model (LLM) leveraging Googles Vertex AI infrastructure for compu

Mon Dec 1, 2025

$425.60 | -1.85%

Activity

Discover VRTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of VRTX. We're here to help you make informed investment decisions today.

FIND US ON

Receive our VRTX Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

VRTX Stock trends

VRTX Stock performance

VRTX Stock analysis

VRTX investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VRTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing VRTX

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

VRTX Stock Analysis & IQ Rating | Vertex Pharma

VRTX Stock IQ

VRTX Target Price

VRTX Risk Level

VRTX Analysts Opinion

VRTX Street Sentiment

VRTX Performance Sentiment

Technical Price Levels

Explore our VRTX Stock insights

Receive our VRTX Daily Alerts

VRTX Street Sentiment

VRTX Risk Level

Technical Price Levels

Discover VRTX Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of VRTX. We're here to help you make informed investment decisions today.

Receive our VRTX Daily Alerts

VRTX Runner Alarm